Lixte Biotechnology Holdings Inc (LIXT) — Financial Flexibility Index
Lixte Biotechnology Holdings Inc (LIXT) has a Financial Flexibility Index of -0.61x as of December 2025. Free cash flow of $-1.09 Million (operating CF $-1.09 Million minus capex $3.00) represents -1% of total liabilities ($1.77 Million). Check how resilient are Lixte Biotechnology Holdings Inc's assets to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Lixte Biotechnology Holdings Inc Financial Flexibility Index (2005–2025)
Historical Financial Flexibility Index trend for Lixte Biotechnology Holdings Inc across 21 annual periods. See LIXT current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Lixte Biotechnology Holdings Inc (2005–2025)
Year-by-year free cash flow to debt coverage for Lixte Biotechnology Holdings Inc. For the full company profile including market capitalisation, see LIXT company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.73x | $-3.07 Million | $-3.07 Million | $1.77 Million | ▲ +82.6% |
| 2024 | -9.94x | $-3.16 Million | $-3.16 Million | $318.28K | ▲ +27.3% |
| 2023 | -13.68x | $-4.29 Million | $-4.29 Million | $313.86K | ▼ -17.1% |
| 2022 | -11.68x | $-4.61 Million | $-4.61 Million | $394.79K | ▲ +14.6% |
| 2021 | -13.68x | $-4.14 Million | $-4.14 Million | $302.93K | ▼ -38.9% |
| 2020 | -9.84x | $-2.13 Million | $-2.13 Million | $216.52K | ▼ -39.9% |
| 2019 | -7.04x | $-1.67 Million | $-1.67 Million | $237.90K | ▲ +1.8% |
| 2018 | -7.16x | $-1.51 Million | $-1.51 Million | $210.91K | ▼ -89.2% |
| 2017 | -3.79x | $-1.41 Million | $-1.41 Million | $373.02K | ▲ +50.7% |
| 2016 | -7.67x | $-1.68 Million | $-1.68 Million | $218.65K | ▼ -0.5% |
| 2015 | -7.64x | $-2.18 Million | $-2.18 Million | $285.64K | ▼ -27.7% |
| 2014 | -5.98x | $-1.64 Million | $-1.64 Million | $273.44K | ▼ -63.1% |
| 2013 | -3.67x | $-1.18 Million | $-1.18 Million | $321.77K | ▲ +20.6% |
| 2012 | -4.62x | $-1.21 Million | $-1.21 Million | $261.15K | ▼ -19.1% |
| 2011 | -3.88x | $-1.36 Million | $-1.36 Million | $350.75K | ▲ +19.2% |
| 2010 | -4.80x | $-936.39K | $-936.39K | $195.06K | ▼ -125.8% |
| 2009 | -2.13x | $-638.44K | $-638.44K | $300.26K | ▼ -33.5% |
| 2008 | -1.59x | $-597.69K | $-597.69K | $375.20K | ▲ +42.8% |
| 2007 | -2.79x | $-702.60K | $-702.87K | $252.18K | ▲ +21.7% |
| 2006 | -3.56x | $-442.95K | $-443.45K | $124.50K | ▼ -35.3% |
| 2005 | -2.63x | $-32.87K | $-32.87K | $12.50K | — |